NIH-funded research Career grant

Understanding how platelets interact with fibrin to improve blood clotting

Official title: Dissecting the Mechanims of Platelet-Fibrin interaction

Funded at Rockefeller University · NIH-10914262 · Data updated 2026-11-12

This study is looking at how platelets, which help your blood clot, interact with a protein called fibrin, and it's trying to find new ways to prevent unwanted blood clots, which could help people with bleeding and clotting issues.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionRockefeller University
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2025
Funding year2024
Award (this year)$139,120
NIH project number5K01HL169359-02
Project IDNIH-10914262 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals over 21 years old who have conditions related to blood clotting or bleeding.

Less likely to help

Patients with conditions unrelated to platelet function or blood coagulation may not benefit from this research.

What this research studies

This research investigates the mechanisms by which platelets interact with fibrin, a protein essential for blood clotting. By developing innovative assays, the study aims to differentiate between platelet interactions with fibrinogen and polymerized fibrin, which are crucial for effective clot retraction and stabilization. The research employs high-throughput screening to identify compounds that can inhibit unwanted clot retraction, potentially leading to new treatments for thrombotic conditions. Patients may benefit from insights gained about how to better manage bleeding and clotting disorders.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for patients with bleeding disorders or those at risk of thrombosis.

How similar studies have gone: Previous research has shown promise in understanding platelet interactions, but this approach offers novel insights that have not been extensively tested.

Where this research is happening

  • Rockefeller University
    New York, United States
    Active

Researchers

  • Principal investigator: Buitrago, Claudia Lorena — Rockefeller University
  • Study coordinator: Buitrago, Claudia Lorena

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.